Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 22, Issue 1, 1999, Pages 6-7

  Sanchez Parra M ^a   Churruca, C ^a   Parades, A ^a   Lacasta, A ^a   Lopez de Argumedo G ^a   Alvarez I ^a   Abad, T ^a   Egana, L ^a   Guimon E ^a   Piera, J M ^a  

^a Hospital Nuestra Senora de Aranzazu   (Spain)

Author keywords

5 Fluorouracil; Cisplatin; Head and neck carcinoma; Ifosfamide

Indexed keywords

CISPLATIN; FLUOROURACIL; IFOSFAMIDE; MESNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; HEAD AND NECK CARCINOMA; HUMAN; INFECTION SENSITIVITY; KIDNEY FAILURE; MALE; MUCOSA INFLAMMATION; NEUROTOXICITY; NEUTROPENIA; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0343570064     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-199902000-00002     Document Type: Article

References (8)

1. Cervellino JC, Araujo CE, Pirisi C, Francia A, Cerruti R. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. Oncology 1991;48:89-92.
2. Martin M, Diaz-Rubio E, González JL, et al. Ifosfamide in advanced epidermoid head and neck cancer. Cancer Chemother Pharmacol 1993;31:340-2.
3. Buesa JM, Fernández R, Esteban E, et al. Phase II trial of ifosfamide in recurrent and head and neck cancer. Ann Oncol 1991;2:151-2.
4. Pai VR, Parik DM, Mazundar A, Rao RS. Phase II study of high-dose ifosfamide as a single agent in combination with cis-platin in the treatment of advanced and/or recurrent squamous cell carcinoma of the head and neck. Oncology 1993;50:86-91.
5. Bruno M. Ifosfamide/mesna plus carboplatin as neoadjuvat therapy for stage I-III head and neck cancer, preliminary report. Fourth International Congres of Anticancer Chemotherapy. Paris, France, 1993:71.
6. Gupta V, Arenas, Hial E, et al. High response rate to cisplatin and ifostamide/mesna in head and neck cancer [abstract]. Proceedings of the American Society of Clinical Oncology 1994;13:936.
7. Rixe O, Lacoste JP, Thomas A, et al. Neoadjuvat chemotherapy by CDDP, 5FU, leucovorin and ifosfamide for advanced squamous cell carcinoma of the head and neck [abstract]. Proceedings of the American Society of Clinical Oncology 1994;13:940.
8. World Health Organization. WHO handbook for reporting the results of cancer treatment. Vol. 48. Geneva: WHO Offset Publication, 1979.